Cordasco Financial Network’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$9K Hold
790
0.01% 387
2022
Q1
$15K Buy
790
+305
+63% +$5.67K 0.01% 318
2021
Q4
$13K Hold
485
0.01% 341
2021
Q3
$20K Buy
485
+85
+21% +$4.66K 0.01% 289
2021
Q2
$23K Hold
400
0.02% 281
2021
Q1
$17K Sell
400
-12
-3% -$684 0.01% 298
2020
Q4
$29K Buy
412
+12
+3% +$493 0.02% 214
2020
Q3
$11K Hold
400
0.01% 299
2020
Q2
$12K Buy
+400
New +$10.5K 0.01% 261

Other funds holding EDIT

Cordasco Financial Network's EDIT Position: Q2 2022 in Review

Cordasco Financial Network held its Editas Medicine (EDIT) position steady in Q2 2022 at 790 shares worth $9K. The position accounts for 0.01% of the portfolio, ranked #387.

Cordasco Financial Network first reported a position in EDIT in Q2 2020 and has held it in 9 quarters since. The position peaked at $29K in Q4 2020. 257 funds tracked by Wall St. Rank hold EDIT as of Q2 2022.

  • Cordasco Financial Network held 790 shares of Editas Medicine worth $9K as of Q2 2022.
  • Cordasco Financial Network left its Editas Medicine share count unchanged in Q2 2022.
  • Editas Medicine made up 0.01% of Cordasco Financial Network's portfolio in Q2 2022, its #387 holding.
  • Cordasco Financial Network first reported a position in Editas Medicine in Q2 2020 and has held it in 9 quarters since.
  • Cordasco Financial Network's Editas Medicine position peaked at $29K in Q4 2020.
  • 257 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2022.

Based on Cordasco Financial Network's 13F filing for Q2 2022, filed 15 Jul 2022.